Effects of auranofin on leukotriene production and leukotriene stimulated neutrophil function

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Agents and Actions

• Publication date

  1984-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF01966773PMID 6099693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolism of Arachidonic Acid in Polymorphonuclear Leukocytes

  2002cited by this paper
• Effects of gold compounds on function of phagocytic cells

  1986cited by this paper
• Auranofin affects early events in human polymorphonuclear neutrophil activation by receptor-mediated stimuli.

  1984cited by this paper
• Effects of gold compounds on the function of phagocytic cells. II. Inhibition of superoxide radical generation by tripeptide-activated polymorphonuclear leukocytes.

  1983cited by this paper
• Modulation of neutrophil functions by auranofin. Studies on effects in vitro and in rheumatoid arthritis patients.

  1983cited by this paper
• Effects of novel lipoxygenase products on neutrophil and eosinophil functions in vitro.

  1983cited by this paper
• Comparative biological activities of synthetic leukotriene b4 and its ω-oxidation products

  1983cited by this paper
• Comparative biological activities of synthetic leukotriene B4 and its omega-oxidation products.

  1983cited by this paper
• Leukotriene‐induced neutrophil aggregation in vitro

  1982cited by this paper
• Modulation of Neutrophil Functions by Auranofin

  1982cited by this paper
• A novel leukotriene produced by stimulation of leukocytes with formylmethionylleucylphenylalanine.

  1982cited by this paper
• Effects of gold compounds on the function of phagocytic cells. I. Suppression of phagocytosis and the generation of chemiluminescence by polymorphonuclear leukocytes.

  1982cited by this paper
• Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.

  1982cited by this paper
• Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis.

  1982cited by this paper
• Transformation of 15‐hydroperoxy‐5,9,11,13‐eicosatetraenoic acid into novel leukotrienes

  1981cited by this paper
• Identification and biological activity of novel omega-oxidized metabolites of leukotriene B4 from human leukocytes.

  1981cited by this paper
• Stimulation of human leukocyte degranulation by leukotriene B4 and its omega-oxidized metabolites.

  1981cited by this paper
• The quantification of neutrophil orientation and migration under agarose--a new method for detecting directed and random movements.

  1981cited by this paper
• Identification and biological activity of novel ω‐oxidized metabolites of leukotriene B4 from human leukocytes

  1981cited by this paper
• Serum-coated zymosan stimulates the synthesis of leukotriene B4 in human polymorphonuclear leukocytes. Inhibition by cyclic AMP.

  1981cited by this paper
• Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence.

  1981cited by this paper
• Leukotriene B4 — a stereospecific stimulator for release of lysosomal enzymes from neutrophils

  1981cited by this paper
• Stimulation of human leukocyte degranulation by leukotriene B4 and its ω‐oxidized metabolites

  1981cited by this paper
• Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids.

  1980cited by this paper
• The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).

  1980cited by this paper
• The inhibitory effects of BW 755C on arachidonic acid metabolism in human polymorphonuclear leukocytes

  1980cited by this paper
• Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

  1980cited by this paper
• Leukotriene A. Isolation from human polymorphonuclear leukocytes.

  1980cited by this paper
• Leukotrienes and Slow Reacting Substance of Anaphylaxis (SRS‐A)

  1980cited by this paper
• Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.

  1980cited by this paper
• A role for endogenous mono-hydroxy-eicosatetraenoic acids (HETEs) in the regulation of human neutrophil migration.

  1980cited by this paper
• Leukotriene B4: a highly potent and stereospecific factor stimulating migration of polymorphonuclear leukocytes.

  1980cited by this paper
• Inhibition of rabbit neutrophil lysosomal enzyme secretion, non-stimulated and chemotactic factor stimulated locomotion by nordihydroguaiaretic acid.

  1980cited by this paper
• Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils.

  1980cited by this paper
• Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids.

  1979cited by this paper
• Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

  1979cited by this paper
• Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds.

  1979cited by this paper
• Effect of auranofin, a new antiarthritic agent, on immune complex-induced release of lysosomal enzymes from human leukocytes

  1977cited by this paper
• Lysosomal mechanisms of tissue injury in arthritis.

  1972cited by this paper
• The urinary excretion of lysozyme in dogs.

  1970cited by this paper

• CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide

  2014cites this paper
• drugsmodulate histamine release frommastcells induced byfibrinogen degradation products

  2011cites this paper
• Inverse Relationship between 15-Lipoxygenase-2 and PPAR- g Gene Expression in Normal Epithelia Compared with Tumor Epithelia 1

  2005cites this paper
• Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia.

  2005cites this paper
• Novel immunosuppressants in asthma.

  2000cites this paper
• A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial.

  1996cites this paper
• Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils.

  1990cites this paper
• Effect of auranofin on eicosanoids and protein kinase C in human neutrophils

  1989cites this paper
• Oral chrysotherapy with auranofin in dogs.

  1989cites this paper
• Stimulatory effects of anti-rheumatic drugs on human neutrophil functions.

  1988cites this paper
• Studies on the effects of disease-modifying antirheumatic drugs on lipoxygenase product synthesis in human neutrophils in vitro.

  1988cites this paper
• Anti-inflammatory drugs modulate histamine release from mast cells induced by fibrinogen degradation products.

  1988cites this paper
• Auranofin modulates gelatinase release from rat neutrophils.

  1987cites this paper
• Differential inhibitory effects of auranofin on leukotriene B4 and leukotriene C4 formation by human polymorphonuclear leukocytes.

  1987cites this paper